BHVN Stock Analysis: Buy, Sell, or Hold?
BHVN - Biohaven Ltd.
$15.44
1.27 (8.96%)
▲
5d:
-0.71%
30d:
+27.71%
90d:
+54.25%
BUY
MODERATE Confidence
Analysis Updated: Jul 17, 2026 12:00 AM ET
Earnings: Aug 10, 2026
22d
Smart Money Accumulation
None View Scanner →
Strength: 7.7/10
Get Alerted When BHVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BHVN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: BHVN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: BHVN is currently trading at $15.44, which is considered slightly high relative to its 30-day fair value range of $12.50 to $16.10.
Technical Outlook: Technically, BHVN is in a strong uptrend. Immediate support is located at $13.62, while resistance sits at $17.28. The stock is showing strong short-term momentum, up 9.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $21.94 (+42.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BHVN is in a strong uptrend. Immediate support is located at $13.62, while resistance sits at $17.28. The stock is showing strong short-term momentum, up 9.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $21.94 (+42.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$12.50 -
$16.10
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+9.0%)
- BULLISH: Trading 42.1% below Wall St target ($21.94)
Trading Range Analysis
30-Day Trading Range
$12.50 -
$16.10
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$13.62
Resistance Level
$17.28
Current Trend
Strong Uptrend
Technical data as of
Jul 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.92
Wall Street Target
$21.94
(+42.1%)
Share & Embed Analysis
Last updated: July 18, 2026 5:26 PM ET
Data refreshes hourly during market hours. Next update: 6:26 PM
Data refreshes hourly during market hours. Next update: 6:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BHVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 60 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 61 BUY |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 53 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$105 | 51 HOLD |
Advanced BHVN Option Strategies
Professional options setups generated by AI based on today's BHVN price and gamma walls.
